$CBMG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cellular Biomedicine Group, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cellular Biomedicine Group, Inc.. Get notifications about new insider transactions in Cellular Biomedicine Group, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | M | 3.00 | 1,296 | 3,888 | 161,089 | 159.8 K to 161.1 K (+0.81 %) | |
| Oct 21 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Sell | S | 20.50 | 2,403 | 49,262 | 159,793 | 162.2 K to 159.8 K (-1.48 %) | |
| Oct 21 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Sell | S | 20.50 | 1,516 | 31,078 | 162,196 | 163.7 K to 162.2 K (-0.93 %) | |
| Oct 21 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | M | 5.61 | 1,516 | 8,505 | 163,712 | 162.2 K to 163.7 K (+0.93 %) | |
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Option Exercise | M | 3.00 | 33,333 | 99,999 | 0 | ||
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Option Exercise | M | 5.61 | 1,516 | 8,505 | 45,484 | ||
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Option Exercise | M | 3.00 | 1,296 | 3,888 | 45,371 | ||
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | M | 3.00 | 33,333 | 99,999 | 162,196 | 128.9 K to 162.2 K (+25.87 %) | |
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Sell | S | 20.80 | 25,115 | 522,392 | 128,863 | 154 K to 128.9 K (-16.31 %) | |
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Sell | S | 20.80 | 1,516 | 31,533 | 153,978 | 155.5 K to 154 K (-0.97 %) | |
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | M | 5.61 | 1,516 | 8,505 | 155,494 | 154 K to 155.5 K (+0.98 %) | |
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Sell | S | 20.80 | 1,296 | 26,957 | 153,978 | 155.3 K to 154 K (-0.83 %) | |
| Sep 23 2015 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | M | 3.00 | 1,296 | 3,888 | 155,274 | 154 K to 155.3 K (+0.84 %) | |
| Aug 21 2015 | CBMG | Cellular Biomedici ... | Yao Yihong | Chief Scientific Of ... | Option Exercise | A | 26.53 | 25,000 | 663,250 | 25,000 | |
| Aug 21 2015 | CBMG | Cellular Biomedici ... | Yao Yihong | Chief Scientific Of ... | Grant | A | 0.00 | 25,000 | 0 | 25,500 | 500 to 25.5 K (+5,000.00 %) |
| Jun 10 2015 | CBMG | Cellular Biomedici ... | Liu Wen Tao | Executive Chairman | Option Exercise | M | 3.00 | 33,333 | 99,999 | 0 | |
| Jun 10 2015 | CBMG | Cellular Biomedici ... | Liu Wen Tao | Executive Chairman | Buy | M | 3.00 | 33,333 | 99,999 | 224,076 | 190.7 K to 224.1 K (+17.48 %) |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 15.53 | 8,000 | 124,240 | 396,100 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 15.53 | 97,800 | 1,518,834 | 388,100 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 20.63 | 15,000 | 309,450 | 290,300 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 20.63 | 15,000 | 309,450 | 275,300 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Wen Tao | Executive Chairman | Option Exercise | A | 15.53 | 33,667 | 522,849 | 213,667 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Cao Wei (William) | Chief Executive Off ... | Option Exercise | A | 15.53 | 101,000 | 1,568,530 | 3,410,000 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Cao Wei (William) | Chief Executive Off ... | Option Exercise | A | 20.63 | 30,000 | 618,900 | 240,000 | |
| Feb 17 2015 | CBMG | Cellular Biomedici ... | Cao Wei (William) | Chief Executive Off ... | Option Exercise | A | 20.63 | 30,000 | 618,900 | 210,000 | |
| Dec 24 2014 | CBMG | Cellular Biomedici ... | Leung Pak To | 10% Owner | Option Exercise | S | 8.00 | 620,000 | 4,960,000 | 0 | |
| Dec 24 2014 | CBMG | Cellular Biomedici ... | Leung Pak To | 10% Owner | Option Exercise | X | 8.00 | 380,000 | 3,040,000 | 0 | |
| Dec 24 2014 | CBMG | Cellular Biomedici ... | Leung Pak To | 10% Owner | Sell | S | 14.00 | 142,857 | 1,999,998 | 791,920 | 934.8 K to 791.9 K (-15.28 %) |
| Dec 24 2014 | CBMG | Cellular Biomedici ... | Leung Pak To | 10% Owner | Buy | X | 8.00 | 380,000 | 3,040,000 | 934,777 | 554.8 K to 934.8 K (+68.50 %) |
| Nov 13 2014 | CBMG | Cellular Biomedici ... | Liu Wen Tao | Executive Chairman | Buy | J | 0.00 | 2,403 | 0 | 188,340 | 185.9 K to 188.3 K (+1.29 %) |
| Oct 31 2014 | CBMG | Cellular Biomedici ... | Cao Wei (William) | Chief Executive Off ... | Buy | J | 0.00 | 1,602 | 0 | 25,145 | 23.5 K to 25.1 K (+6.80 %) |
| Oct 09 2014 | CBMG | Cellular Biomedici ... | Liu Wen Tao | Executive Chairman | Buy | J | 0.00 | 68,225 | 0 | 188,340 | 120.1 K to 188.3 K (+56.80 %) |
| Oct 08 2014 | CBMG | Cellular Biomedici ... | Cao Wei (William) | Chief Executive Off ... | Buy | J | 0.00 | 23,543 | 0 | 23,543 | 0 to 23.5 K |
| Oct 06 2014 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | J | 0.00 | 22,822 | 0 | 152,376 | 129.6 K to 152.4 K (+17.62 %) | |
| Aug 18 2014 | CBMG | Cellular Biomedici ... | Chan Andrew K | Option Exercise | A | 5.61 | 47,000 | 263,670 | 127,000 | ||
| Aug 18 2014 | CBMG | Cellular Biomedici ... | Chan Andrew K | Buy | J | 0.00 | 3,000 | 0 | 129,554 | 126.6 K to 129.6 K (+2.37 %) | |
| Jul 03 2014 | CBMG | Cellular Biomedici ... | Bolocan David | Director | Buy | P | 5.00 | 10,000 | 50,000 | 10,000 | 0 to 10 K |
| May 30 2014 | CBMG | Cellular Biomedici ... | Cao Wei (William) | Chief Executive Off ... | Buy | P | 5.00 | 100,000 | 500,000 | 222,518 | 122.5 K to 222.5 K (+81.62 %) |
| May 30 2014 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 5.00 | 300,000 | 1,500,000 | 169,200 | 469.2 K to 169.2 K (-63.94 %) |
| May 30 2014 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Buy | P | 5.00 | 100,000 | 500,000 | 100,000 | 0 to 100 K |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 7.00 | 150 | 1,050 | 474,070 | 474.2 K to 474.1 K (-0.03 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 7.00 | 300 | 2,100 | 474,070 | 474.4 K to 474.1 K (-0.06 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 6.60 | 400 | 2,640 | 474,070 | 474.5 K to 474.1 K (-0.08 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 6.60 | 600 | 3,960 | 474,070 | 474.7 K to 474.1 K (-0.13 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 7.18 | 1,000 | 7,180 | 475,520 | 476.5 K to 475.5 K (-0.21 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Grant | A | 5.00 | 30,000 | 150,000 | 476,520 | 446.5 K to 476.5 K (+6.72 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Gift | G | 0.00 | 980,000 | 0 | 44,652,000 | 45.6 M to 44.7 M (-2.15 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Gift | G | 0.00 | 600,000 | 0 | 44,652,000 | 45.3 M to 44.7 M (-1.33 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Gift | G | 0.00 | 1,800,000 | 0 | 44,652,000 | 46.5 M to 44.7 M (-3.87 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.11 | 12,600 | 1,386 | 48,032,000 | 48 M to 48 M (-0.03 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.11 | 80,000 | 8,800 | 48,032,000 | 48.1 M to 48 M (-0.17 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.09 | 61,185 | 5,201 | 48,124,600 | 48.2 M to 48.1 M (-0.13 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.09 | 3,815 | 324 | 48,124,600 | 48.1 M to 48.1 M (-0.01 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.07 | 60,000 | 4,200 | 48,124,600 | 48.2 M to 48.1 M (-0.12 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.06 | 50,000 | 3,000 | 48,249,600 | 48.3 M to 48.2 M (-0.10 %) |
| Aug 09 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Sell | S | 0.06 | 50,000 | 2,750 | 48,249,600 | 48.3 M to 48.2 M (-0.10 %) |
| May 07 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Gift | G | 0.00 | 600,000 | 0 | 469,200 | 1.1 M to 469.2 K (-56.12 %) |
| May 07 2013 | CBMG | Cellular Biomedici ... | Wong Keith | Director | Gift | G | 0.00 | 1,800,000 | 0 | 469,200 | 2.3 M to 469.2 K (-79.32 %) |
| Apr 17 2013 | CBMG | Cellular Biomedici ... | Liu Tony | Director | Buy | P | 5.00 | 700 | 3,500 | 700 | 0 to 700 |
| Apr 02 2013 | CBMG | Cellular Biomedici ... | Dai Jianping | Director | Option Exercise | A | 4.95 | 5,300 | 26,235 | 5,300 | |
| Feb 22 2013 | CBMG | Cellular Biomedici ... | Cao Wei (William) | President and COO | Option Exercise | A | 3.00 | 56,667 | 170,001 | 90,000 | |
| Feb 22 2013 | CBMG | Cellular Biomedici ... | Cao Wei (William) | President and COO | Option Exercise | A | 3.00 | 33,333 | 99,999 | 33,333 | |
| Feb 22 2013 | CBMG | Cellular Biomedici ... | Chan Andrew K | CFO and Secretary | Option Exercise | A | 3.00 | 46,667 | 140,001 | 80,000 | |
| Feb 22 2013 | CBMG | Cellular Biomedici ... | Chan Andrew K | CFO and Secretary | Option Exercise | A | 3.00 | 33,333 | 99,999 | 33,333 | |
| Feb 22 2013 | CBMG | Cellular Biomedici ... | Liu Wen Tao (Steve) | CEO | Option Exercise | A | 3.00 | 146,667 | 440,001 | 180,000 | |
| Feb 22 2013 | CBMG | Cellular Biomedici ... | Liu Wen Tao (Steve) | CEO | Option Exercise | A | 3.00 | 33,333 | 99,999 | 33,333 | |
| Feb 11 2011 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | S | 0.08 | 1,407,885 | 112,631 | 13,832,196 | 12.4 M to 13.8 M (+11.33 %) |
| Oct 05 2010 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | S | 0.07 | 537,115 | 34,912 | 15,240,081 | 15.8 M to 15.2 M (-3.40 %) |
| May 21 2010 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Grant | A | 0.11 | 818,182 | 90,000 | 15,777,196 | 15 M to 15.8 M (+5.47 %) |
| May 21 2010 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | D | 0.10 | 300,000 | 30,000 | 14,959,014 | 15.3 M to 15 M (-1.97 %) |
| Feb 18 2010 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Grant | A | 0.06 | 2,541,564 | 152,494 | 15,259,014 | 12.7 M to 15.3 M (+19.98 %) |
| Jan 25 2010 | CBMG | Cellular Biomedici ... | Wong Keith | President | Buy | P | 0.03 | 7,300,000 | 182,500 | 52,390,180 | 45.1 M to 52.4 M (+16.19 %) |
| Jan 25 2010 | CBMG | Cellular Biomedici ... | Wong Keith | President | Sell | S | 0.04 | 3,750,000 | 150,000 | 45,090,180 | 48.8 M to 45.1 M (-7.68 %) |
| Jan 25 2010 | CBMG | Cellular Biomedici ... | Wong Keith | President | Gift | G | 0.00 | 1,800,000 | 0 | 48,840,180 | 50.6 M to 48.8 M (-3.55 %) |
| Aug 21 2009 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | S | 0.02 | 923,712 | 16,627 | 12,717,450 | 13.6 M to 12.7 M (-6.77 %) |
| Aug 21 2009 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Grant | A | 0.02 | 1,400,000 | 28,000 | 13,641,162 | 12.2 M to 13.6 M (+11.44 %) |
| May 22 2009 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operating ... | Sell | P | 0.02 | 641,720 | 9,626 | 12,241,162 | 12.9 M to 12.2 M (-4.98 %) |
| Mar 13 2009 | CBMG | Cellular Biomedici ... | dembinski leo joseph | Director | Sell | P | 0.02 | 69,816 | 1,396 | 4,100,000 | 4.2 M to 4.1 M (-1.67 %) |
| Feb 25 2009 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | P | 0.02 | 508,700 | 8,648 | 12,882,882 | 13.4 M to 12.9 M (-3.80 %) |
| Feb 25 2009 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.02 | 500,000 | 10,000 | 13,391,582 | 12.9 M to 13.4 M (+3.88 %) |
| Feb 04 2009 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | S | 0.04 | 1,800,000 | 72,000 | 50,640,180 | 52.4 M to 50.6 M (-3.43 %) |
| Feb 04 2009 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Buy | P | 0.04 | 1,500,000 | 60,000 | 52,440,180 | 50.9 M to 52.4 M (+2.94 %) |
| Feb 04 2009 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Gift | G | 0.00 | 5,000,000 | 0 | 50,940,180 | 55.9 M to 50.9 M (-8.94 %) |
| Feb 03 2009 | CBMG | Cellular Biomedici ... | EastBridge Investment Group Co ... | CEO | Buy | S | 0.04 | 1,800,000 | 72,000 | 50,640,180 | 48.8 M to 50.6 M (+3.69 %) |
| Feb 03 2009 | CBMG | Cellular Biomedici ... | EastBridge Investment Group Co ... | CEO | Buy | P | 0.04 | 1,500,000 | 60,000 | 52,440,180 | 50.9 M to 52.4 M (+2.94 %) |
| Feb 03 2009 | CBMG | Cellular Biomedici ... | EastBridge Investment Group Co ... | CEO | Gift | G | 0.00 | 5,000,000 | 0 | 50,940,180 | 55.9 M to 50.9 M (-8.94 %) |
| Nov 14 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | P | 0.03 | 49,284 | 1,479 | 12,842,298 | 12.9 M to 12.8 M (-0.38 %) |
| Nov 14 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.03 | 1,125,000 | 33,750 | 12,891,582 | 11.8 M to 12.9 M (+9.56 %) |
| Oct 20 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | P | 0.03 | 723,114 | 21,693 | 11,766,582 | 12.5 M to 11.8 M (-5.79 %) |
| Oct 15 2008 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Buy | P | 0.03 | 5,000,000 | 150,000 | 55,940,180 | 50.9 M to 55.9 M (+9.82 %) |
| Oct 15 2008 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | S | 0.04 | 1,100,000 | 38,500 | 50,940,180 | 52 M to 50.9 M (-2.11 %) |
| Sep 18 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | P | 0.03 | 503,300 | 15,099 | 12,489,696 | 13 M to 12.5 M (-3.87 %) |
| Sep 18 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Grant | A | 0.03 | 4,002,000 | 120,060 | 12,992,996 | 9 M to 13 M (+44.51 %) |
| Jul 09 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | S | 0.04 | 600,000 | 24,000 | 8,990,996 | 9.6 M to 9 M (-6.26 %) |
| May 22 2008 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Buy | P | 0.09 | 1,333,333 | 120,000 | 53,106,031 | 51.8 M to 53.1 M (+2.58 %) |
| May 27 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.07 | 5,000 | 350 | 9,590,996 | 9.6 M to 9.6 M (+0.05 %) |
| May 27 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | S | 0.07 | 120,900 | 8,463 | 9,585,996 | 9.7 M to 9.6 M (-1.25 %) |
| May 27 2008 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | S | 0.07 | 600,000 | 42,000 | 52,040,180 | 52.6 M to 52 M (-1.14 %) |
| May 22 2008 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | S | 0.08 | 465,851 | 37,268 | 52,640,180 | 53.1 M to 52.6 M (-0.88 %) |
| Feb 28 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.07 | 1,000,000 | 70,000 | 9,706,896 | 8.7 M to 9.7 M (+11.49 %) |
| Feb 28 2008 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Sell | P | 0.08 | 800,000 | 64,000 | 8,706,896 | 9.5 M to 8.7 M (-8.41 %) |
| Dec 06 2007 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | D | 0.09 | 774,179 | 69,676 | 51,772,698 | 52.5 M to 51.8 M (-1.47 %) |
| Nov 06 2007 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.10 | 100,000 | 10,000 | 9,256,896 | 9.2 M to 9.3 M (+1.09 %) |
| Nov 06 2007 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.07 | 2,233,563 | 156,349 | 9,356,896 | 7.1 M to 9.4 M (+31.36 %) |
| Aug 30 2007 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Corporate Operation ... | Buy | P | 0.07 | 400,000 | 28,000 | 7,123,333 | 6.7 M to 7.1 M (+5.95 %) |
| Aug 03 2007 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | S | 0.07 | 328,840 | 23,019 | 52,146,877 | 52.5 M to 52.1 M (-0.63 %) |
| Aug 30 2007 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Buy | D | 0.07 | 400,000 | 28,000 | 52,546,877 | 52.1 M to 52.5 M (+0.77 %) |
| Jun 21 2007 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Sell | P | 0.13 | 54,732 | 7,115 | 51,969,585 | 52 M to 52 M (-0.11 %) |
| Feb 22 2007 | CBMG | Cellular Biomedici ... | Klein Norman Paul II | Coporate Operations ... | Buy | P | 0.30 | 473,333 | 142,000 | 16,473,333 | 16 M to 16.5 M (+2.96 %) |
| Feb 22 2007 | CBMG | Cellular Biomedici ... | Wong Keith | CEO | Buy | P | 0.30 | 1,655,077 | 496,523 | 52,024,317 | 50.4 M to 52 M (+3.29 %) |